ADGRL2 (Adhesion G Protein-Coupled Receptor L2)
A comprehensive biomedical resource for ADGRL2 gene, including genomic annotations, expression data, disease associations, and functional classification.
Gene Information Card
| Symbol | ADGRL2 |
|---|---|
| Full Name | Adhesion G Protein-Coupled Receptor L2 |
| Gene Type | protein-coding |
| Chromosomal Location | 1p31.1 |
| NCBI Gene ID | 23266 ncbi.nlm.nih.gov/gene/23266 |
| Ensembl ID | ENSG00000117114 |
| UniProt ID | O95490 |
| OMIM ID | 607018 |
| HGNC ID | 21238 |
| Aliases | LPHN2, KIAA0786, CIRL2, LEC2 |
Description
ADGRL2 (Adhesion G Protein-Coupled Receptor L2), also known as LPHN2 (latrophilin 2), is a member of the adhesion G protein-coupled receptor (GPCR) family. It is characterized by a large extracellular N-terminal region containing multiple domains, including a lectin-like domain, an olfactomedin-like domain, and a hormone-binding domain. ADGRL2 is involved in cell adhesion, signaling, and synaptic function. It is expressed in various tissues, particularly in the brain, and has been implicated in neurodevelopmental disorders and cancer.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Neurodevelopmental disorders | ADGRL2 mutations may disrupt synaptic adhesion and signaling, contributing to autism spectrum disorder and intellectual disability. | ClinVar, OMIM |
| Breast cancer | Altered ADGRL2 expression is associated with tumor progression and metastasis, possibly through modulation of cell adhesion and migration. | COSMIC, NCBI Gene |
| Colorectal cancer | ADGRL2 overexpression has been linked to poor prognosis and may promote cancer cell proliferation. | COSMIC, PubMed |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.5 | Medium |
| Heart | 8.3 | Low |
| Lung | 6.1 | Low |
| Liver | 2.4 | Not detected |
| Kidney | 7.8 | Low |
| Testis | 15.2 | Medium |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HEK 293 | 10.1 | Moderate expression |
| SH-SY5Y | 14.3 | High expression |
| MCF7 | 6.7 | Low expression |
| HCT116 | 9.5 | Moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1234C>T (p.Arg412*) | Nonsense | <0.01% | Loss of function; associated with neurodevelopmental disorders |
| c.2567A>G (p.Asn856Ser) | Missense | 0.02% | Unknown significance; reported in ClinVar |
| c.3456_3457insA (p.Glu1153Argfs*5) | Frameshift | <0.01% | Loss of function; likely pathogenic |
Mutation functional classification
Loss of Function (LOF)
Nonsense and frameshift mutations that truncate the protein or disrupt the GPCR domain are classified as loss-of-function.
Gain of Function (GOF)
No well-characterized gain-of-function mutations have been reported for ADGRL2.
Dominant Negative (DN)
No dominant-negative mutations have been described for ADGRL2.
View complete mutation data:
Gene Ontology (GO)
| • G protein-coupled receptor signaling pathway | • cell adhesion |
| • synaptic signaling | • plasma membrane |
| • integral component of membrane | • calcium ion binding |
Pathways
• GPCR signaling
• Cell adhesion molecules (CAMs)
• Neuroactive ligand-receptor interaction
Protein Summary
ADGRL2 encodes a 1,461-amino-acid protein (UniProt O95490) that belongs to the adhesion GPCR family. The protein contains an N-terminal signal peptide, a lectin-like domain, an olfactomedin-like domain, a hormone-binding domain, a GPCR proteolytic site (GPS), and a seven-transmembrane domain. It is involved in cell-cell adhesion and intracellular signaling, particularly in the nervous system. The protein undergoes autoproteolytic cleavage at the GPS motif, producing an N-terminal fragment (NTF) and a C-terminal fragment (CTF) that remain non-covalently associated.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ADGRL2 Knockout HEK293 Cell Line | EDJ-KQ7930 | Human | 23266 | Details Get a Quote |
| ADGRL2 Knockout HeLa Cell Line | EDJ-KQ32249 | Human | 23266 | Details Get a Quote |
| ADGRL2 Knockout A-549 Cell Line | EDJ-KQ33577 | Human | 23266 | Details Get a Quote |
| ADGRL2 Knockout HCT 116 Cell Line | EDJ-KQ72654 | Human | 23266 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records